Our study aimed to address this knowledge gap by evaluating the alteration rates of PI3K and TP53 pathway‐related genes among early‐onset and late‐onset CRC patients within the Hispanic/Latino population and comparing these findings to early‐onset non‐Hispanic White patients. The gene discussed is PIK3CG; the disease is colorectal carcinoma.